Journal of Clinical Oncology, Vol 7, 1201-1207, Copyright © 1989 by American Society of Clinical Oncology

ARTICLES

Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee

SE Krown, C Metroka and JC Wernz
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

The availability of uniform and precise criteria for disease evaluation, response to treatment, and clinical staging of Kaposi's sarcoma (KS) in individuals with the acquired immune deficiency syndrome (AIDS) would facilitate therapeutic trials in patients with this neoplasm. Recently, a group of oncologists conducting clinical trials in patients with AIDS-associated KS as part of a cooperative group established by the National Institute of Allergy and Infectious Diseases (NIAID) drafted such criteria. The criteria take into account the unique problems associated with the evaluation of patients with a disseminated cutaneous neoplasm in the setting of a systemic virus infection associated with immune deficiency. The recommendations include a standardized format for documenting the extent of KS on initial and subsequent evaluations, response definitions that include assessments of lesion nodularity and tumor-associated edema in addition to more traditional methods for evaluating tumor response, and a new staging system that includes extent of tumor, immune status, and other AIDS-related disease manifestations, akin to the tumor-node-metastasis (TNM) system used to stage other tumors. The adoption of standardized criteria for the evaluation of KS should prove useful for group trials and for other investigators involved in the treatment of this disease.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J.-P. Spano, D. Costagliola, C. Katlama, N. Mounier, E. Oksenhendler, and D. Khayat AIDS-Related Malignancies: State of the Art and Therapeutic Challenges J. Clin. Oncol., October 10, 2008; 26(29): 4834 - 4842. [Abstract] [Full Text] [PDF]

				R. F. Little, K. Aleman, P. Kumar, K. M. Wyvill, J. M. Pluda, E. Read-Connole, V. Wang, S. Pittaluga, A. T. Catanzaro, S. M. Steinberg, et al. Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma Blood, December 15, 2007; 110(13): 4165 - 4171. [Abstract] [Full Text] [PDF]

				A. Berkenblit, J. P. Eder Jr., D. P. Ryan, M. V. Seiden, N. Tatsuta, M. L. Sherman, T. A. Dahl, B. J. Dezube, and J. G. Supko Phase I Clinical Trial of STA-4783 in Combination with Paclitaxel in Patients with Refractory Solid Tumors Clin. Cancer Res., January 15, 2007; 13(2): 584 - 590. [Abstract] [Full Text] [PDF]

				R. F. Little, J. M. Pluda, K. M. Wyvill, I. R. Rodriguez-Chavez, G. Tosato, A. T. Catanzaro, S. M. Steinberg, and R. Yarchoan Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma Blood, June 15, 2006; 107(12): 4650 - 4657. [Abstract] [Full Text] [PDF]

				A. M. Levine, A. Tulpule, D. I. Quinn, G. Gorospe III, D. L. Smith, L. Hornor, W. D. Boswell, B. M. Espina, S. G. Groshen, R. Masood, et al. Phase I Study of Antisense Oligonucleotide Against Vascular Endothelial Growth Factor: Decrease in Plasma Vascular Endothelial Growth Factor With Potential Clinical Efficacy J. Clin. Oncol., April 10, 2006; 24(11): 1712 - 1719. [Abstract] [Full Text] [PDF]

				B. J. Dezube, S. E. Krown, J. Y. Lee, K. S. Bauer, and D. M. Aboulafia Randomized Phase II Trial of Matrix Metalloproteinase Inhibitor COL-3 in AIDS-Related Kaposi's Sarcoma: An AIDS Malignancy Consortium Study J. Clin. Oncol., March 20, 2006; 24(9): 1389 - 1394. [Abstract] [Full Text] [PDF]

				J. Stebbing, D. Mazhar, R. Lewis, C. Palmieri, E. Hatzimichael, M. Nelson, B. Gazzard, and M. Bower The presentation and survival of patients with non-cutaneous AIDS-associated Kaposi's sarcoma Ann. Onc., March 1, 2006; 17(3): 503 - 506. [Abstract] [Full Text] [PDF]

				A. J. Stratigos, D. Malanos, G. Touloumi, A. Antoniou, I. Potouridou, D. Polydorou, A. D. Katsambas, D. Whitby, N. Mueller, J. D. Stratigos, et al. Association of Clinical Progression in Classic Kaposi's Sarcoma With Reduction of Peripheral B Lymphocytes and Partial Increase in Serum Immune Activation Markers Arch Dermatol, November 1, 2005; 141(11): 1421 - 1426. [Abstract] [Full Text] [PDF]

				M. C. Cheung, L. Pantanowitz, and B. J. Dezube AIDS-Related Malignancies: Emerging Challenges in the Era of Highly Active Antiretroviral Therapy Oncologist, June 1, 2005; 10(6): 412 - 426. [Abstract] [Full Text] [PDF]

				H. B. Koon, G. J. Bubley, L. Pantanowitz, D. Masiello, B. Smith, K. Crosby, J. Proper, W. Weeden, T. E. Miller, P. Chatis, et al. Imatinib-Induced Regression of AIDS-Related Kaposi's Sarcoma J. Clin. Oncol., February 10, 2005; 23(5): 982 - 989. [Abstract] [Full Text] [PDF]

				R. Dagher, J. Johnson, G. Williams, P. Keegan, and R. Pazdur Accelerated Approval of Oncology Products: A Decade of Experience J Natl Cancer Inst, October 20, 2004; 96(20): 1500 - 1509. [Abstract] [Full Text] [PDF]

				J. Stebbing, B. Gazzard, S. Patterson, M. Bower, D. Perumal, M. Nelson, A. McMichael, G. Ogg, A. Epenetos, F. Gotch, et al. Antibody-targeted MHC complex-directed expansion of HIV-1- and KSHV-specific CD8+ lymphocytes: a new approach to therapeutic vaccination Blood, March 1, 2004; 103(5): 1791 - 1795. [Abstract] [Full Text] [PDF]

				S. E. Krown Highly Active Antiretroviral Therapy in AIDS-Associated Kaposi's Sarcoma: Implications for the Design of Therapeutic Trials in Patients With Advanced, Symptomatic Kaposi's Sarcoma J. Clin. Oncol., February 1, 2004; 22(3): 399 - 402. [Full Text] [PDF]

				J. Stebbing, B. Gazzard, S. Portsmouth, F. Gotch, L. Kim, M. Bower, S. Mandalia, R. Binder, P. Srivastava, and S. Patterson Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptor Blood, September 1, 2003; 102(5): 1806 - 1814. [Abstract] [Full Text] [PDF]

				G. Nasti, R. Talamini, A. Antinori, F. Martellotta, G. Jacchetti, F. Chiodo, G. Ballardini, L. Stoppini, G. Di Perri, M. Mena, et al. AIDS-Related Kaposi's Sarcoma: Evaluation of Potential New Prognostic Factors and Assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals J. Clin. Oncol., August 1, 2003; 21(15): 2876 - 2882. [Abstract] [Full Text] [PDF]

				D. M. Aboulafia, D. Norris, D. Henry, R. J. Grossman, J. Thommes, D. Bundow, R. C. Yocum, and V. Stevens 9-cis-Retinoic Acid Capsules in the Treatment of AIDS-Related Kaposi Sarcoma: Results of a Phase 2 Multicenter Clinical Trial Arch Dermatol, February 1, 2003; 139(2): 178 - 186. [Abstract] [Full Text] [PDF]

				S. Topino, L. Vincenzi, I. Mezzaroma, E. Nicastri, M. Andreoni, and M. C. Sirianni Correlation between Enzyme-Linked Immunosorbent Assay and Immunofluorescence Assay with Lytic Antigens for Detection of Antibodies to Human Herpesvirus 8 Clin. Vaccine Immunol., January 1, 2001; 8(1): 203 - 205. [Abstract] [Full Text] [PDF]

				A. M. Cattelan, M. L. Calabro, P. Gasperini, S. M. L. Aversa, M. Zanchetta, F. Meneghetti, A. De Rossi, and L. Chieco-Bianchi Acquired Immunodeficiency Syndrome-Related Kaposi's Sarcoma Regression After Highly Active Antiretroviral Therapy: Biologic Correlates of Clinical Outcome J Natl Cancer Inst Monographs, December 1, 2000; 2000(28): 44 - 49. [Abstract] [Full Text] [PDF]

				M. Duvic, A. E. Friedman-Kien, D. J. Looney, S. A. Miles, P. L. Myskowski, D. T. Scadden, J. Von Roenn, J. E. Galpin, J. Groopman, G. Loewen, et al. Topical Treatment of Cutaneous Lesions of Acquired Immunodeficiency Syndrome-Related Kaposi Sarcoma Using Alitretinoin Gel: Results of Phase 1 and 2 Trials Arch Dermatol, December 1, 2000; 136(12): 1461 - 1469. [Abstract] [Full Text] [PDF]

				R. F. Little, K. M. Wyvill, J. M. Pluda, L. Welles, V. Marshall, W. D. Figg, F. M. Newcomb, G. Tosato, E. Feigal, S. M. Steinberg, et al. Activity of Thalidomide in AIDS-Related Kaposi's Sarcoma J. Clin. Oncol., July 1, 2000; 18(13): 2593 - 2602. [Abstract] [Full Text] [PDF]

				D. M. Aboulafia The Epidemiologic, Pathologic, and Clinical Features of AIDS-Associated Pulmonary Kaposi’s Sarcoma Chest, April 1, 2000; 117(4): 1128 - 1145. [Abstract] [Full Text] [PDF]

				A. Tulpule, D. T. Scadden, B. M. Espina, S. Cabriales, W. Howard, K. Shea, and P. S. Gill Results of a Randomized Study of IM862 Nasal Solution in the Treatment of AIDS-Related Kaposi’s Sarcoma J. Clin. Oncol., February 14, 2000; 18(4): 716 - 716. [Abstract] [Full Text] [PDF]

				T. W. Cheung, S. C. Remick, N. Azarnia, J. A. Proper, J. R. Barrueco, and B. J. Dezube AIDS-related Kaposi's Sarcoma: A Phase II Study of Liposomal Doxorubicin Clin. Cancer Res., November 1, 1999; 5(11): 3432 - 3437. [Abstract] [Full Text] [PDF]

				M. Thornton, L. Barkley, J. C. Mason, and S. Shaunak Anti-Kaposi's Sarcoma and Antiangiogenic Activities of Sulfated Dextrins Antimicrob. Agents Chemother., October 1, 1999; 43(10): 2528 - 2533. [Abstract] [Full Text] [PDF]

				P. S. Gill, A. Tulpule, B. M. Espina, S. Cabriales, J. Bresnahan, M. Ilaw, S. Louie, N. F. Gustafson, M. A. Brown, C. Orcutt, et al. Paclitaxel Is Safe and Effective in the Treatment of Advanced AIDS-Related Kaposi's Sarcoma J. Clin. Oncol., June 1, 1999; 17(6): 1876 - 1876. [Abstract] [Full Text] [PDF]

				S. E. Krown Clinical Overview: Issues in Kaposi's Sarcoma Therapeutics J Natl Cancer Inst Monographs, April 1, 1998; 1998(23): 59 - 63. [Abstract] [Full Text]

				J. Patel Liposomal doxorubicin: Doxil(R) Journal of Oncology Pharmacy Practice, December 1, 1996; 2(4): 201 - 210. [Abstract] [PDF]

				S. Poignonec, L. D. Lachiver, G. Lamas, A. Coutellier, E. Caumes, and J. Soudant Intralesional Bleomycin for Acquired Immunodeficiency Syndrome-Associated Cutaneous Kaposi's Sarcoma Arch Dermatol, February 1, 1995; 131(2): 228 - 228. [Abstract] [PDF]

				S. E. Krown, J. W.M. Gold, D. Niedzwiecki, D. Bundow, N. Flomenberg, B. Gansbacher, and B. J. Brew Interferon-{alpha} with Zidovudine: Safety, Tolerance, and Clinical and Virologic Effects in Patients with Kaposi Sarcoma Associated with the Acquired Immunodeficiency Syndrome (AIDS) Ann Intern Med, June 1, 1990; 112(11): 812 - 821. [Abstract] [PDF]

				S. A. Miles, H. Wang, E. Cortes, J. Carden, S. Marcus, and R. T. Mitsuyasu Beta-Interferon Therapy in Patients with Poor-Prognosis Kaposi Sarcoma Related to the Acquired Immunodeficiency Syndrome (AIDS) A Phase II Trial with Preliminary Evidence of Antiviral Activity and Low Incidence of Opportunistic Infections Ann Intern Med, April 15, 1990; 112(8): 582 - 589. [Abstract] [PDF]